Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditions.

Autor: Duminuco A; Division of Hematology and BMT Unit, A.O.U. Policlinico G.Rodolico-San Marco, Catania, Italy., Nardo A; Division of Hematology and BMT Unit, A.O.U. Policlinico G.Rodolico-San Marco, Catania, Italy., Orofino A; Division of Hematology and BMT Unit, A.O.U. Policlinico G.Rodolico-San Marco, Catania, Italy., Giunta G; Division of Hematology and BMT Unit, A.O.U. Policlinico G.Rodolico-San Marco, Catania, Italy., Conticello C; Division of Hematology and BMT Unit, A.O.U. Policlinico G.Rodolico-San Marco, Catania, Italy., Del Fabro V; Division of Hematology and BMT Unit, A.O.U. Policlinico G.Rodolico-San Marco, Catania, Italy., Chiarenza A; Division of Hematology and BMT Unit, A.O.U. Policlinico G.Rodolico-San Marco, Catania, Italy., Parisi MS; Division of Hematology and BMT Unit, A.O.U. Policlinico G.Rodolico-San Marco, Catania, Italy., Figuera A; Division of Hematology and BMT Unit, A.O.U. Policlinico G.Rodolico-San Marco, Catania, Italy., Leotta S; Division of Hematology and BMT Unit, A.O.U. Policlinico G.Rodolico-San Marco, Catania, Italy., Milone G; Division of Hematology and BMT Unit, A.O.U. Policlinico G.Rodolico-San Marco, Catania, Italy., Cupri A; Division of Hematology and BMT Unit, A.O.U. Policlinico G.Rodolico-San Marco, Catania, Italy., Cambria D; Division of Hematology and BMT Unit, A.O.U. Policlinico G.Rodolico-San Marco, Catania, Italy., Di Raimondo F; Division of Hematology and BMT Unit, A.O.U. Policlinico G.Rodolico-San Marco, Catania, Italy.; Dipartimento di Specialità Medico-Chirurgiche, CHIRMED, Sezione di Ematologia University of Catania, Catania, Italy., Romano A; Division of Hematology and BMT Unit, A.O.U. Policlinico G.Rodolico-San Marco, Catania, Italy.; Dipartimento di Specialità Medico-Chirurgiche, CHIRMED, Sezione di Ematologia University of Catania, Catania, Italy., Palumbo GA; Division of Hematology and BMT Unit, A.O.U. Policlinico G.Rodolico-San Marco, Catania, Italy.; Department of Scienze Mediche Chirurgiche e Tecnologie Avanzate G.F. Ingrassia, University of Catania, Catania, Italy.

Publikováno v: Cancer [Cancer] 2024 Jan 01; Vol. 130 (1), pp. 41-50. Date of Electronic Publication: 2023 Sep 01.

Off-Label Use of Venetoclax in Patients With Acute Myeloid Leukemia: Single Center Experience and Data From Pharmacovigilance Database.

Autor: Gozzo L; Clinical Pharmacology Unit/Regional Pharmacovigilance Centre, A.O.U. Policlinico 'G.Rodolico-S.Marco', Catania, Italy.; Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy., Vetro C; Haematology Unit, A.O.U. Policlinico 'G.Rodolico-S.Marco', Catania, Italy., Brancati S; Clinical Pharmacology Unit/Regional Pharmacovigilance Centre, A.O.U. Policlinico 'G.Rodolico-S.Marco', Catania, Italy., Longo L; Clinical Pharmacology Unit/Regional Pharmacovigilance Centre, A.O.U. Policlinico 'G.Rodolico-S.Marco', Catania, Italy., Vitale DC; Clinical Pharmacology Unit/Regional Pharmacovigilance Centre, A.O.U. Policlinico 'G.Rodolico-S.Marco', Catania, Italy., Romano GL; Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy., Mauro E; Haematology Unit, A.O.U. Policlinico 'G.Rodolico-S.Marco', Catania, Italy., Fiumara PF; Haematology Unit, A.O.U. Policlinico 'G.Rodolico-S.Marco', Catania, Italy., Maugeri C; Haematology Unit, A.O.U. Policlinico 'G.Rodolico-S.Marco', Catania, Italy., Parisi MS; Haematology Unit, A.O.U. Policlinico 'G.Rodolico-S.Marco', Catania, Italy., Dulcamare I; Haematology Unit, A.O.U. Policlinico 'G.Rodolico-S.Marco', Catania, Italy., Garibaldi B; Postgraduate School of Hematology, University of Catania, Catania, Italy., Duminuco A; Postgraduate School of Hematology, University of Catania, Catania, Italy., Palumbo GA; Haematology Unit, A.O.U. Policlinico 'G.Rodolico-S.Marco', Catania, Italy.; Department of Scienze Mediche Chirurgiche e Tecnologie Avanzate 'G.F. Ingrassia', University of Catania, Catania, Italy., Di Raimondo F; Haematology Unit, A.O.U. Policlinico 'G.Rodolico-S.Marco', Catania, Italy.; Department of Chirurgia Generale e Specialità Medico-Chirurgiche, University of Catania, Catania, Italy., Drago F; Clinical Pharmacology Unit/Regional Pharmacovigilance Centre, A.O.U. Policlinico 'G.Rodolico-S.Marco', Catania, Italy.; Department of Biomedical and Biotechnological Sciences, University of Catania, Catania, Italy.; Centre for Research and Consultancy in HTA and Drug Regulatory Affairs (CERD) University of Catania, Catania, Italy.

Publikováno v: Frontiers in pharmacology [Front Pharmacol] 2021 Nov 11; Vol. 12, pp. 748766. Date of Electronic Publication: 2021 Nov 11 (Print Publication: 2021).

Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey.

Autor: Markovic U; Postgraduate School of Hematology, University of Catania, Catania, Italy.; Division of Hematology, University Hospital Policlinico Vittorio Emanuele, Catania, Italy., Romano A; Postgraduate School of Hematology, University of Catania, Catania, Italy.; Department of General Surgery and Medical-Surgical Specialties, University of Catania, Catania, Italy., Del Fabro V; Division of Hematology, University Hospital Policlinico Vittorio Emanuele, Catania, Italy., Bellofiore C; Postgraduate School of Hematology, University of Catania, Catania, Italy.; Division of Hematology, University Hospital Policlinico Vittorio Emanuele, Catania, Italy., Bulla A; Postgraduate School of Hematology, University of Catania, Catania, Italy.; Division of Hematology, University Hospital Policlinico Vittorio Emanuele, Catania, Italy., Parisi MS; Division of Hematology, University Hospital Policlinico Vittorio Emanuele, Catania, Italy., Leotta S; Division of Hematology, University Hospital Policlinico Vittorio Emanuele, Catania, Italy., Gentile M; Unit of Clinical Hematology, Cosenza Hospital, Cosenza, Italy., Cangialosi C; Unitá Operativa Complessa Ematologia, Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello, Palermo, Italy., Vincelli I; Unità Operativa Complessa di Ematologia, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy., Mineo G; Unitá Operativa Semplice Dipartimentale Ematologia, Ospedale San Vincenzo, Taormina, Italy., Rossi M; Department of Clinical and Experimental Medicine, Magna Græcia University of Catanzaro, Catanzaro, Italy., Poidomani M; Servizio di Immunoematologia e Medicina Trasfusionale, Ematologia ASP Ragusa, Ragusa, Italy., Uccello G; Unità Operativa Complessa Ematologia, Garibaldi Nesima Hospital, Catania, Italy., Maugeri C; Division of Hematology, University Hospital Policlinico Vittorio Emanuele, Catania, Italy.; Division of Hematology, Sant'Elia Hospital, Caltanissetta, Italy., Mannina D; Division of Hematology, Papardo Hospital, Messina, Italy., Innao V; Division of Hematology, Department of Human Pathology in Adulthood and Childhood, Policlinico 'G. Martino', University of Messina, Messina, Italy., Di Raimondo F; Postgraduate School of Hematology, University of Catania, Catania, Italy.; Division of Hematology, University Hospital Policlinico Vittorio Emanuele, Catania, Italy.; Department of General Surgery and Medical-Surgical Specialties, University of Catania, Catania, Italy., Conticello C; Division of Hematology, University Hospital Policlinico Vittorio Emanuele, Catania, Italy.

Publikováno v: Frontiers in oncology [Front Oncol] 2021 Mar 05; Vol. 11, pp. 624405. Date of Electronic Publication: 2021 Mar 05 (Print Publication: 2021).

Clinical Benefit of Long-Term Disease Control with Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients.

Autor: Parisi MS; Division of Hematology, AOU 'Policlinico - Vittorio Emanuele', Via Santa Sofia 78, 95124 Catania, Italy. marinaparisi@hotmail.it., Leotta S; Division of Hematology, AOU 'Policlinico - Vittorio Emanuele', Via Santa Sofia 78, 95124 Catania, Italy. leotta3@yahoo.it., Romano A; Department of General Surgery and Medical-Surgical Specialties, Haematology Section, University of Catania, Via Santa Sofia 78, 95124 Catania, Italy. sandrina.romano@gmail.com., Del Fabro V; Division of Hematology, AOU 'Policlinico - Vittorio Emanuele', Via Santa Sofia 78, 95124 Catania, Italy. vdelfabro@yahoo.it., Martino EA; Department of General Surgery and Medical-Surgical Specialties, Haematology Section, University of Catania, Via Santa Sofia 78, 95124 Catania, Italy. enricaantoniamartino@libero.it., Calafiore V; Department of General Surgery and Medical-Surgical Specialties, Haematology Section, University of Catania, Via Santa Sofia 78, 95124 Catania, Italy. valeriacalaf@gmail.com., Giubbolini R; Department of General Surgery and Medical-Surgical Specialties, Haematology Section, University of Catania, Via Santa Sofia 78, 95124 Catania, Italy. r.giubbolini10@gmail.com., Markovic U; Department of General Surgery and Medical-Surgical Specialties, Haematology Section, University of Catania, Via Santa Sofia 78, 95124 Catania, Italy. urosmarkovic09041989@gmail.com., Leotta V; Department of General Surgery and Medical-Surgical Specialties, Haematology Section, University of Catania, Via Santa Sofia 78, 95124 Catania, Italy. valerio_leotta@yahoo.it., Di Giorgio MA; Department of General Surgery and Medical-Surgical Specialties, Haematology Section, University of Catania, Via Santa Sofia 78, 95124 Catania, Italy. maryanndg@live.it., Tibullo D; Department of Biomedical and Biotechnological Science, University of Catania, 95124 Catania, Italy. d.tibullo@unict.it., Di Raimondo F; Department of General Surgery and Medical-Surgical Specialties, Haematology Section, University of Catania, Via Santa Sofia 78, 95124 Catania, Italy. diraimon@gmail.com., Conticello C; Division of Hematology, AOU 'Policlinico - Vittorio Emanuele', Via Santa Sofia 78, 95124 Catania, Italy. ettaconticello@gmail.com.

Publikováno v: Journal of clinical medicine [J Clin Med] 2019 Oct 16; Vol. 8 (10). Date of Electronic Publication: 2019 Oct 16.

Feasibility, Tolerability and Efficacy of Carfilzomib in Combination with Lenalidomide and Dexamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real-Life Survey of the Sicilian Myeloma Network.

Autor: Conticello C; Division of Hematology, Azienda Policlinico-OVE, University of Catania, 95125 Catania, Italy. ettaconticello@gmail.com., Romano A; Division of Hematology, Azienda Policlinico-OVE, University of Catania, 95125 Catania, Italy. sandrina.romano@gmail.com., Del Fabro V; Division of Hematology, Azienda Policlinico-OVE, University of Catania, 95125 Catania, Italy. vdelfabro@yahoo.it., Martino EA; Division of Hematology, Azienda Policlinico-OVE, University of Catania, 95125 Catania, Italy. enricaantoniamartino@libero.it., Calafiore V; Division of Hematology, Azienda Policlinico-OVE, University of Catania, 95125 Catania, Italy. valeriacalaf@gmail.com., Sapienza G; Division of Hematology, Azienda Policlinico-OVE, University of Catania, 95125 Catania, Italy. sapienzagius@gmail.com., Leotta V; Division of Hematology, Azienda Policlinico-OVE, University of Catania, 95125 Catania, Italy. valerio_leotta@yahoo.it., Parisi MS; Division of Hematology, Azienda Policlinico-OVE, University of Catania, 95125 Catania, Italy. marinaparisi@hotmail.it., Markovic U; Division of Hematology, Azienda Policlinico-OVE, University of Catania, 95125 Catania, Italy. urosmarkovic09041989@gmail.com., Garibaldi B; Division of Hematology, Azienda Policlinico-OVE, University of Catania, 95125 Catania, Italy. brunga93@gmail.com., Leotta S; Division of Hematology, Azienda Policlinico-OVE, University of Catania, 95125 Catania, Italy. leotta3@yahoo.it., Cotzia E; U.O.C. Ematologia, ASP8, 96100 Siracusa, Italy. cotemi@hotmail.it., Innao V; Division of Hematology, Dipartimento di Patologia Umana dell'Adulto e dell'Età Evolutiva, Policlinico G. Martino, University of Messina, 98122 Messina, Italy. vinnao@unime.it., Mannina D; U.O.C. Ematologia, Azienda Ospedaliera Papardo, 98158 Messina, Italy. donamanni@gmail.com., Neri S; U.O.C. Ematologia, Azienda Ospedaliera Papardo, 98158 Messina, Italy. santoneri67@gmail.com., Musso M; U.O.C. OncoEmatologia e TMO, Dipartimento Oncologico, La Maddalena, 90146 Palermo, Italy. mamusso53@gmail.com., Scalone R; U.O.C. OncoEmatologia e TMO, Dipartimento Oncologico, La Maddalena, 90146 Palermo, Italy. r.scalone69@gmail.com., Cangialosi C; U.O.C. Ematologia A. O. Ospedali Riuniti Villa Sofia-Cervello, 90146 Palermo, Italy. clotildecangialosi@gmail.com., Acquaviva F; U.O.C. Ematologia A. O. Ospedali Riuniti Villa Sofia-Cervello, 90146 Palermo, Italy. clotildecangialosi@hotmail.com., Cardinale G; U.O.C. Ematologia, ARNAS-Civico-Di Cristina-Benfratelli, 90147 Palermo, Italy. cardinaleg@libero.it., Merenda A; U.O.C. Ematologia, ARNAS-Civico-Di Cristina-Benfratelli, 90147 Palermo, Italy. anxur.merenda@arnascivico.it., Maugeri C; Division of Hematology, Sant'Elia Hospital, 93100 Caltanissetta, Italy. maugericinzia@hotmail.com., Uccello G; U.O.C. Ematologia, ARNAS Garibaldi, 95122 Catania, Italy. giusy83@virgilio.it., Poidomani M; SIMT Hematology, ASP7, 97100 Ragusa, Italy. massimo.poidomani@asp.rg.it., Longo G; U.O.C. Ematologia, Ospedale San Vincenzo, 98039 Taormina (ME), Italy. longo_giuseppe@hotmail.com., Carlisi M; U.O.C. Ematologia, Policlinico P. Giaccone, 90127 Palermo, Italy. melania.carlisi@unipa.it., Tibullo D; Department of Biomedical and Biotechnological Science, University of Catania, 95125 Catania, Italy. d.tibullo@unict.it., Di Raimondo F; Division of Hematology, Azienda Policlinico-OVE, University of Catania, 95125 Catania, Italy. diraimon@unict.it.

Publikováno v: Journal of clinical medicine [J Clin Med] 2019 Jun 19; Vol. 8 (6). Date of Electronic Publication: 2019 Jun 19.